Substituted pyridines as irreversible inhibitors of menin-MLL interaction | Patent Number 11084825

US 11084825 B2
Application Number16732226
Publication NumberUS 20200223853 A1
Pendency1 year, 7 months, 13 days
Filled DateDec 31, 2019
Priority DateDec 31, 2018
Publication DateJul 16, 2020
Expiration DateDec 30, 2038
Inventor/ApplicantsMatthew Welsch
Brendan Kelly
Ravi Upasani
Jim Palmer
Edward Painter
Sridhar Vempati
Thomas Butler
ExaminesWILLIS, DOUGLAS M
Art Unit1624
Technology Center1600
Assignments
Biomea Fusion Llc
Current
Biomea Fusion Llc
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.